Jan W Robering
Overview
Explore the profile of Jan W Robering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
An R, Strissel P, Al-Abboodi M, Robering J, Supachai R, Eckstein M, et al.
Bioengineering (Basel)
. 2022 Jul;
9(7).
PMID: 35877331
Animal models are important tools to investigate the pathogenesis and develop treatment strategies for breast cancer in humans. In this study, we developed a new three-dimensional in vivo arteriovenous loop...
2.
Schmitz D, Robering J, Weisbach V, Arkudas A, Ludolph I, Horch R, et al.
J Cell Mol Med
. 2022 Jul;
26(16):4463-4478.
PMID: 35818175
Adipose-derived stromal cells (ADSC) are increasingly used in clinical applications due to their regenerative capabilities. However, ADSC therapies show variable results. This study analysed the effects of specific factors of...
3.
Robering J, Al-Abboodi M, Titzmann A, Horn I, Beier J, Horch R, et al.
Tissue Eng Part A
. 2020 Jun;
27(1-2):129-141.
PMID: 32524901
Various therapeutic approaches, for example, in case of trauma or cancer require the transplantation of autologous tissue. Depending on the size and the origin of the harvested tissue, these therapies...
4.
Ahmadzadeh N, Robering J, Kengelbach-Weigand A, Al-Abboodi M, Beier J, Horch R, et al.
Exp Cell Res
. 2020 Jan;
388(2):111816.
PMID: 31923426
Lymphedema is a chronic progressive disease ultimately resulting in severe, disfiguring swelling and permanent changes of the affected tissues. Presently, there is no causal treatment approach of lymphedema. Therefore, most...
5.
Robering J, Gebhardt L, Wolf K, Kuhn H, Kremer A, Fischer M
Glia
. 2019 Jan;
67(5):999-1012.
PMID: 30637823
Pruritus is a common and disabling symptom in patients with hepatobiliary disorders, particularly in those with cholestatic features. Serum levels of lysophosphatidic acid (LPA) and its forming enzyme autotaxin were...
6.
Schmid R, Wolf K, Robering J, Strauss S, Strissel P, Strick R, et al.
BMC Cancer
. 2018 Dec;
18(1):1273.
PMID: 30567518
Background: Breast cancer is the most common malignancy in women affecting one out of eight females throughout their lives. Autotaxin (ATX) is upregulated in breast cancer which results in increased...
7.
Robering J, Weigand A, Pfuhlmann R, Horch R, Beier J, Boos A
J Cell Mol Med
. 2018 May;
22(8):3740-3750.
PMID: 29752774
Lymphatic metastasis is one of the main prognostic factors concerning long-term survival of cancer patients. In this regard, the molecular mechanisms of lymphangiogenesis are still rarely explored. Also, the interactions...
8.
An R, Schmid R, Klausing A, Robering J, Weber M, Bauerle T, et al.
FASEB J
. 2018 May;
32(10):5587-5601.
PMID: 29746168
Endothelial progenitor cells (EPCs) contribute to neovascularization in tumors. However, the relationship of EPCs and tumor-induced angiogenesis still remains to be clarified. The present study aimed at investigating the influence...